John Lewicki

Directeur Technique/Scientifique/R&D chez MEREO BIOPHARMA GROUP PLC

Fortune : 2 046 $ au 30/04/2024

72 ans

Health Technology

Consumer Services

Postes actifs de John Lewicki

Sociétés	Poste	Début	Fin
MEREO BIOPHARMA GROUP PLC	Directeur Technique/Scientifique/R&D	01/07/2020	-

Sociétés	Poste	Début	Fin
ONCOMED PHARMACEUTICALS INC	Directeur/Membre du Conseil	19/03/2018	23/04/2019
	Directeur Général	19/03/2018	23/04/2019
	Directeur Technique/Scientifique/R&D	01/01/2004	21/02/2018
	President	21/02/2018	23/04/2019
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Directeur Technique/Scientifique/R&D	-	-
	Corporate Officer/Principal	01/01/1983	01/01/2000

University of California San Diego

Doctorate Degree

Internationale

Etats-Unis	4
Royaume-Uni	2

Opérationnelle

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
MEREO BIOPHARMA GROUP PLC	Health Technology

Entreprise privées	2
OncoMed Pharmaceuticals, Inc. OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.	Health Technology
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.	Health Technology

Entreprise privées

Health Technology